RS51082B - Sinergistička kombinacija koja uključuje roflumilas i (r.r.) -formoterol - Google Patents

Sinergistička kombinacija koja uključuje roflumilas i (r.r.) -formoterol

Info

Publication number
RS51082B
RS51082B YUP-2005/0383A YUP20050383A RS51082B RS 51082 B RS51082 B RS 51082B YU P20050383 A YUP20050383 A YU P20050383A RS 51082 B RS51082 B RS 51082B
Authority
RS
Serbia
Prior art keywords
formoterol
roflumilas
compresing
synergistic combination
synergistic
Prior art date
Application number
YUP-2005/0383A
Other languages
English (en)
Inventor
Degenhard Dr. Marx
Christian Dr. Weimar
Daniela Dr. Bundschuh
Rolf Dr. Beume
Stefan-Lutz dr. WOLLIN
Original Assignee
Nycomed Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh. filed Critical Nycomed Gmbh.
Publication of RS20050383A publication Critical patent/RS20050383A/sr
Publication of RS51082B publication Critical patent/RS51082B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Medikament koji sadrži roflumilast, farmakološki prihvatljivu so roflumilasta ili N-oksid roflumilasta u kombinaciji sa R, R-formoterolom ili farmakološki prihvatljivom soli R,R-formoterola.Prijava sadrži još 12 patentnih zahteva.
YUP-2005/0383A 2002-11-27 2003-11-26 Sinergistička kombinacija koja uključuje roflumilas i (r.r.) -formoterol RS51082B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02026504 2002-11-27
PCT/EP2003/013266 WO2004047828A1 (en) 2002-11-27 2003-11-26 Synergistic combination compresing roflumilas and (r.r) -formoterol

Publications (2)

Publication Number Publication Date
RS20050383A RS20050383A (en) 2007-08-03
RS51082B true RS51082B (sr) 2010-10-31

Family

ID=32338001

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2005/0383A RS51082B (sr) 2002-11-27 2003-11-26 Sinergistička kombinacija koja uključuje roflumilas i (r.r.) -formoterol

Country Status (32)

Country Link
US (1) US20060199865A1 (sr)
EP (1) EP1567140B1 (sr)
JP (1) JP2006508993A (sr)
KR (1) KR20050094810A (sr)
CN (1) CN1713902A (sr)
AT (1) ATE399544T1 (sr)
AU (1) AU2003288169B8 (sr)
BR (1) BR0316475A (sr)
CA (1) CA2506956C (sr)
CO (1) CO5690571A2 (sr)
CY (1) CY1110368T1 (sr)
DE (1) DE60321954D1 (sr)
DK (1) DK1567140T3 (sr)
EA (1) EA009990B1 (sr)
ES (1) ES2309374T3 (sr)
HK (1) HK1081862A1 (sr)
HR (1) HRP20050580B1 (sr)
IL (1) IL168307A (sr)
IS (1) IS2576B (sr)
MA (1) MA27538A1 (sr)
ME (1) ME00488B (sr)
MX (1) MXPA05005438A (sr)
NO (1) NO334148B1 (sr)
NZ (1) NZ540658A (sr)
PL (1) PL214869B1 (sr)
PT (1) PT1567140E (sr)
RS (1) RS51082B (sr)
SI (1) SI1567140T1 (sr)
TN (1) TNSN05130A1 (sr)
UA (1) UA83017C2 (sr)
WO (1) WO2004047828A1 (sr)
ZA (1) ZA200503307B (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
ATE447555T1 (de) 2003-03-10 2009-11-15 Nycomed Gmbh Neues verfahren zur herstellung vonroflumilast
EP2258350B1 (en) 2005-03-16 2014-12-24 Takeda GmbH Taste masked dosage form containing roflumilast
WO2013077830A1 (en) * 2011-11-25 2013-05-30 Mahmut Bilgic Synergistilly active combinations of roflumilast and carmoterol
CN103784443A (zh) * 2014-02-18 2014-05-14 青岛市城阳区人民医院 一种包含沙美特罗和罗氟司特的药物组合产品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
CA2271004C (en) * 1996-11-11 2007-05-01 Sepracor Inc. Process for the preparation of optically pure isomers of formoterol
WO1998035683A1 (en) * 1997-02-17 1998-08-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
DE59814173D1 (de) * 1997-02-28 2008-04-03 Nycomed Gmbh Synergistische kombination von pde-hemmern und adenylatcyclase-agonisten bzw. guanylcyclyse-agonisten
PL346271A1 (en) * 1998-08-26 2002-01-28 Smithkline Beecham Corp Therapies for treating pulmonary diseases
US6303145B2 (en) * 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
JP5038568B2 (ja) * 1999-08-21 2012-10-03 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 協力剤の組合せ物
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
ES2296923T3 (es) * 2001-03-22 2008-05-01 Glaxo Group Limited Derivados formanilidas como agonistas del adrenorreceptor beta2.
ES2314052T3 (es) * 2001-04-30 2009-03-16 Glaxo Group Limited Derivados de ester de 17beta-carbotioato de androstano con un grupo ester ciclico en la posicion 17alfa.

Also Published As

Publication number Publication date
DK1567140T3 (da) 2008-11-03
PL214869B1 (pl) 2013-09-30
RS20050383A (en) 2007-08-03
ES2309374T3 (es) 2008-12-16
JP2006508993A (ja) 2006-03-16
AU2003288169B2 (en) 2010-01-07
TNSN05130A1 (en) 2007-05-14
AU2003288169A1 (en) 2004-06-18
MXPA05005438A (es) 2005-08-03
US20060199865A1 (en) 2006-09-07
AU2003288169B8 (en) 2010-08-26
IS7899A (is) 2005-06-20
KR20050094810A (ko) 2005-09-28
HK1081862A1 (en) 2006-05-26
PL375632A1 (en) 2005-12-12
NO20053023L (no) 2005-06-20
PT1567140E (pt) 2008-09-24
CN1713902A (zh) 2005-12-28
DE60321954D1 (de) 2008-08-14
NZ540658A (en) 2007-03-30
IS2576B (is) 2010-02-15
UA83017C2 (uk) 2008-06-10
WO2004047828A1 (en) 2004-06-10
IL168307A (en) 2010-12-30
MA27538A1 (fr) 2005-09-01
ATE399544T1 (de) 2008-07-15
EP1567140B1 (en) 2008-07-02
CA2506956A1 (en) 2004-06-10
ZA200503307B (en) 2006-11-29
BR0316475A (pt) 2005-10-11
CO5690571A2 (es) 2006-10-31
EA009990B1 (ru) 2008-04-28
HRP20050580A2 (en) 2006-08-31
HRP20050580B1 (hr) 2014-04-11
EA200500865A1 (ru) 2005-12-29
EP1567140A1 (en) 2005-08-31
ME00488B (me) 2011-10-10
CA2506956C (en) 2012-10-02
NO334148B1 (no) 2013-12-16
SI1567140T1 (sl) 2008-12-31
CY1110368T1 (el) 2015-04-29

Similar Documents

Publication Publication Date Title
TNSN05131A1 (en) New synergistic combination comprising roflumilast and formoterol
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
EP1558220A4 (en) ORAL COMPOSITIONS FOR THE TREATMENT OF DISEASES
RS20050344A (en) Treatment for hemorrhagic shock
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
HK1081862A1 (en) Synergistic combination comprising roflumilast and (r,r)-formoterol
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
WO2004103286A3 (en) Compositions of a cyclooxygenase-2 selective inhibitor and a cholimergic agent